These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 319123)

  • 1. Rheoencephalographic and other studies of betahistine in humans. IV. Prolonged administration with improvement in arteriosclerotic dementia.
    Seipel JH; Fisher R; Blatchley RJ; Floam J; Bohm M
    J Clin Pharmacol; 1977; 17(2-3):140-61. PubMed ID: 319123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheoencephalographic and other studies of betahistine in humans: I. The cerebral and peripheral circulatory effects of single doses in normal subjects.
    Seipel JH; Floam JE
    J Clin Pharmacol; 1975; 15(2-3):144-54. PubMed ID: 1123455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheoencephalographic and other studies of betahistine in humans: II. The crerbral and peripheral microcirculatory effects of single doses in geriatric patients with "pure" arteriosclerotic dementia.
    Seipel JH; Fisher R; Floam JE; Bohm M
    J Clin Pharmacol; 1975; 15(2-3):155-62. PubMed ID: 1123456
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheoencephalographic and other studies of betahistine in humans. III. Improved methods of diagnosis and selection in arteriosclerotic dementia.
    Seipel JH; Fisher R; Floam JE; Bohm M
    J Clin Pharmacol; 1977 Jan; 17(1):63-75. PubMed ID: 319118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betahistine hydrochloride (Serc) in cerebrovascular disease: a placebo-controlled study.
    Pathy J; Menon G; Reynolds A; Van Strik R
    Age Ageing; 1977 Aug; 6(3):179-84. PubMed ID: 331920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride.
    Rivera VM; Meyer JS; Baer PE; Faibish GM; Mathew NT; Hartmann A
    J Am Geriatr Soc; 1974 Sep; 22(9):397-406. PubMed ID: 4212512
    [No Abstract]   [Full Text] [Related]  

  • 7. Betahistine in Ménière's disease.
    Wilmot TJ; Menon GN
    J Laryngol Otol; 1976 Sep; 90(9):833-40. PubMed ID: 787460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.
    Meyer JS; Mathew NT; Hartmann A; Rivera VM
    J Clin Pharmacol; 1974; 14(5-6):280-9. PubMed ID: 4208360
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of betahistine hydrochloride with placebo for vertebral-basilar insufficiency: a double-blind study.
    Spruill JH; Toole JF; Kitto W; Miller HE
    Stroke; 1975; 6(2):116-20. PubMed ID: 1092033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betahistine hydrochloride in Méniére's disease.
    Frew IJ; Menon GN
    Postgrad Med J; 1976 Aug; 52(610):501-3. PubMed ID: 790351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo.
    Canty P; Valentine J
    J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Betahistidine hydrochloride in the treatment of vertebro-basilar insufficiency].
    Botez MI
    Encephale; 1975; 1(3):279-86. PubMed ID: 1227823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative responses of the carotid and vertebral arterial systems of rhesus monkeys to betahistine.
    Tomita M; Gotoh F; Sato T; Amano T; Tanahashi N; Tanaka K; Yamamoto M
    Stroke; 1978; 9(4):382-7. PubMed ID: 97809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of experimental myocardial infarct size by combined treatment with methylprednisolone sodium succinate and betahistine hydrochloride.
    Joyce LD; Smith JM; Mauer HG; Lillehei RC
    Adv Shock Res; 1978; 1():235-49. PubMed ID: 400421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind crossover study comparing betahistine and cinnarizine in the treatment of recurrent vertigo in patients in general practice.
    Deering RB; Prescott P; Simmons RL; Downey LJ
    Curr Med Res Opin; 1986; 10(4):209-14. PubMed ID: 3780284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of betahistine hydrochloride in postoperative retinal detachment patients.
    Hagler WS; Shacklett DE
    Ann Ophthalmol; 1971 Jun; 3(6):612-6. PubMed ID: 4276198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H; Kahl S
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study.
    Oosterveld WJ
    J Laryngol Otol; 1984 Jan; 98(1):37-41. PubMed ID: 6363584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniére's disease.
    Aantaa E; Skinhoj A
    Ann Clin Res; 1976 Aug; 8(4):284-7. PubMed ID: 793500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.